Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuanglian Li

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
The AAPS Journal|January 14, 2015
Using DTA and DTAARRAY variables and programming in WinNonlin ASCII models to streamline user-defined calculation and data analysisJun Shen, Shuanglian Li, Ronald R Bowsher, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|October 25, 2024
ANRIL regulates retinoblastoma progression via targeting autophagy by miR-328-3p/TSC1/ULK signalingYang Yang, Yuezhi Zhang, Yanmei Fu, et al.
Clinical Pharmacokinetics|January 24, 2014
Population pharmacokinetic modelling of recombinant factor IX Fc fusion protein (rFIXFc) in patients with haemophilia BLei Diao, Shuanglian Li, Thomas Ludden, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Population pharmacokinetics of recombinant factor VIII Fc fusion proteinIvan Nestorov, Srividya Neelakantan, Thomas M Ludden, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|July 13, 2006
A multitargeted receptor tyrosine kinase inhibitor, SU6668, does not affect the healing of cutaneous full-thickness incisional wounds in SKH-1 miceW Rachel Duan, Shem Patyna, Madeline A Kuhlmann, et al.
Pharmaceutical Research|November 25, 2010
Role of organic cation transporter 1, OCT1 in the pharmacokinetics and toxicity of cis-diammine(pyridine)chloroplatinum(II) and oxaliplatin in miceShuanglian Li, Ying Chen, Shuzhong Zhang, et al.
IUBMB Life|June 26, 2020
CircPDE4B inhibits retinal pathological angiogenesis via promoting degradation of HIF-1α though targeting miR-181cYan Deng, Shurong Li, Shuanglian Li, et al.
Frontiers in Pediatrics|February 23, 2023
Global research status and trends of bronchiectasis in children from 2003 to 2022: A 20-year bibliometric analysisTing Gong, Xueer Wang, Shuanglian Li, et al.
Molecular Cancer Therapeutics|April 8, 2010
Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogueSwati S More, Shuanglian Li, Sook Wah Yee, et al.
Mutagenesis|July 8, 2009
Inter-laboratory evaluation of the bioluminescent Salmonella reverse mutation assay using 10 model chemicalsJoel Ackerman, Rahul Sharma, Jonathan Hitchcock, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
The AAPS Journal|January 14, 2015
Using DTA and DTAARRAY variables and programming in WinNonlin ASCII models to streamline user-defined calculation and data analysisJun Shen, Shuanglian Li, Ronald R Bowsher, et al.
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists|October 25, 2024
ANRIL regulates retinoblastoma progression via targeting autophagy by miR-328-3p/TSC1/ULK signalingYang Yang, Yuezhi Zhang, Yanmei Fu, et al.
Clinical Pharmacokinetics|January 24, 2014
Population pharmacokinetic modelling of recombinant factor IX Fc fusion protein (rFIXFc) in patients with haemophilia BLei Diao, Shuanglian Li, Thomas Ludden, et al.
Clinical Pharmacology in Drug Development|May 4, 2016
Population pharmacokinetics of recombinant factor VIII Fc fusion proteinIvan Nestorov, Srividya Neelakantan, Thomas M Ludden, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|July 13, 2006
A multitargeted receptor tyrosine kinase inhibitor, SU6668, does not affect the healing of cutaneous full-thickness incisional wounds in SKH-1 miceW Rachel Duan, Shem Patyna, Madeline A Kuhlmann, et al.
Pharmaceutical Research|November 25, 2010
Role of organic cation transporter 1, OCT1 in the pharmacokinetics and toxicity of cis-diammine(pyridine)chloroplatinum(II) and oxaliplatin in miceShuanglian Li, Ying Chen, Shuzhong Zhang, et al.
IUBMB Life|June 26, 2020
CircPDE4B inhibits retinal pathological angiogenesis via promoting degradation of HIF-1α though targeting miR-181cYan Deng, Shurong Li, Shuanglian Li, et al.
Frontiers in Pediatrics|February 23, 2023
Global research status and trends of bronchiectasis in children from 2003 to 2022: A 20-year bibliometric analysisTing Gong, Xueer Wang, Shuanglian Li, et al.
Molecular Cancer Therapeutics|April 8, 2010
Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogueSwati S More, Shuanglian Li, Sook Wah Yee, et al.
Mutagenesis|July 8, 2009
Inter-laboratory evaluation of the bioluminescent Salmonella reverse mutation assay using 10 model chemicalsJoel Ackerman, Rahul Sharma, Jonathan Hitchcock, et al.
Pageof 3